Tests for the Clostridium difficile infection are missing up to 20% of cases and falsely diagnosing thousands of others, researchers have said. A study by St George's, University of London, and St ...

A two-step approach for diagnosing C. difficile has been found to be both cost-effective and significantly more sensitive than other methods in use AbstractLewis, J. (2009) Exploring the accuracy and ...

Pro-Lab Diagnostics and Microgen Bioproducts have announced a unique collaboration to provide clinical microbiology laboratories with a C. difficile cytotoxin testing package designed to eliminate the ...

Ireland has no specialised laboratory which would allow hospitals detect what strain of C difficile may be a threat to patients. The absence of the facility was highlighted in a expert group report ...

Please provide your email address to receive an email when new articles are posted on . In the United States, C. difficile is estimated to cause 500,000 infections per year, and roughly one in 11 ...

Nanosphere, Inc. announced that the U.S. Food and Drug Administration (FDA) granted 510(k) clearance permitting marketing of its C.difficile test on the automated sample-to-result Verigene® System.